Adipose-derived stem cells (ASCs) from human subjects with obesity have been demonstrated to enhance IL-17 release by Th17 cells but inhibit the expression of IFN-γ and TNF-α by Th1 cells[54]. The gene discussed is IFNG; the disease is obesity due to melanocortin 4 receptor deficiency.